Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 1788-1794

  Mahajan, Nitin ^a,b   Dhawan, Veena ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Inflammation; RAGE; sRAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CD11B ANTIGEN; GLUCOSE; HIGH MOBILITY GROUP B1 PROTEIN; PROTEIN S 100; PROTEIN VARIANT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

AORTA ARCH SYNDROME; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INFLAMMATION; LIGAND BINDING; MEDIATOR RELEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEGATIVE FEEDBACK; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE;

ATHEROSCLEROSIS; INFLAMMATION; RAGE; SRAGE;

HUMANS; INFLAMMATION; RECEPTORS, IMMUNOLOGIC; VASCULAR DISEASES;

EID: 84885666326     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.05.013     Document Type: Review

References (99)

1. A.M. Schmidt, M. Vianna, and M. Gerlach Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface J Biol Chem 267 1992 14987 14997
2. M. Neeper, A.M. Schmidt, and J. Brett Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins J Biol Chem 267 1992 14998 15004
3. G. Basta Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications Atherosclerosis 196 2008 9 21
4. S. Del Turco, and G. Basta An update on advanced glycation endproducts and atherosclerosis Biofactors 38 2012 266 274
5. D.G. Farmer, and S. Kennedy RAGE, vascular tone and vascular disease Pharmacol Ther 124 2009 185 194
6. G. Fritz RAGE: a single receptor fits multiple ligands Trends Biochem Sci 36 2011 625 632
7. E. Harja, D.X. Bu, and B.I. Hudson Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE -/- mice J Clin Invest 118 2008 183 194
8. L. Park, K.G. Raman, and K.J. Lee Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts Nat Med 4 1998 1025 1031
9. H.J. Huttunen, C. Fages, and H. Rauvala Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways J Biol Chem 274 1999 19919 19924
10. M.A. Hofmann, S. Drury, and C. Fu RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901
11. T. Chavakis, A. Bierhaus, and N. Al-Fakhri The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment J Exp Med 198 2003 1507 1515
12. K. Jandeleit-Dahm, A. Watson, and A. Soro-Paavonen The AGE/RAGE axis in diabetes-accelerated atherosclerosis Clin Exp Pharmacol Physiol 35 2008 329 334
13. N. Mahajan, V. Dhawan, S. Malik, and S. Jain Serum levels of soluble receptor for advanced glycation end products (sRAGE) in Takayasu's arteritis Int J Cardiol 145 2010 589 591
14. N. Mahajan, N. Malik, A. Bahl, and V. Dhawan Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease Atherosclerosis 207 2009 597 602
15. A. Taguchi, D.C. Blood, and G. del Toro Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases Nature 405 2000 354 360
16. M. Koch, S. Chitayat, and B.M. Dattilo Structural basis for ligand recognition and activation of RAGE Structure 18 2010 1342 1352
17. H. Park, F.G. Adsit, and J.C. Boyington The 1.5 A crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding J Biol Chem 285 2010 40762 40770
18. Q. Ding, and J.N. Keller Evaluation of rage isoforms, ligands, and signaling in the brain Biochim Biophys Acta 1746 2005 18 27
19. B.I. Hudson, A.M. Carter, and E. Harja Identification, classification, and expression of RAGE gene splice variants FASEB J 22 2008 1572 1580
20. H. Yonekura, Y. Yamamoto, and S. Sakurai Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury Biochem J 370 2003 1097 1109
21. L. Zhang, M. Bukulin, and E. Kojro Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases J Biol Chem 283 2008 35507 35516
22. A. Raucci, S. Cugusi, and A. Antonelli A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10) FASEB J 22 2008 3716 3727
23. A. Galichet, M. Weibel, and C.W. Heizmann Calcium-regulated intramembrane proteolysis of the RAGE receptor Biochem Biophys Res Commun 370 2008 1 5
24. S. Yamagishi, and T. Matsui Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker Front Biosci (Elite Ed) 2 2010 1184 1195
25. K.H. Gaens, C.D. Stehouwer, and C.G. Schalkwijk Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity Curr Opin Lipidol 24 2013 4 11
26. M. Kaneko, L. Bucciarelli, and Y.C. Hwang Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury Ann N Y Acad Sci 1043 2005 702 709
27. A.W. Stitt, C. He, and S. Friedman Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs Mol Med 3 1997 617 627
28. K. Kiuchi, J. Nejima, T. Takano, M. Ohta, and H. Hashimoto Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients Heart 85 2001 87 91
29. M. Kanauchi, N. Tsujimoto, and T. Hashimoto Advanced glycation end products in nondiabetic patients with coronary artery disease Diabetes Care 24 2001 1620 1623
30. G. Misciagna, G. Logroscino, and G. De Michele Glycated apolipoprotein B and myocardial infarction Nutr Metab Cardiovasc Dis 17 2007 6 12
31. L. Sun, T. Ishida, and T. Yasuda RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice Cardiovasc Res 82 2009 371 381
32. K. Kotani, R. Caccavello, N. Taniguchi, and A. Gugliucci Circulating soluble receptor for advanced glycation end products is inversely correlated to oxidized low-density lipoproteins in asymptomatic subjects J Int Med Res 40 2012 1878 1883
33. J.S. Park, D. Svetkauskaite, and Q. He Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 279 2004 7370 7377
34. J. Tian, A.M. Avalos, and S.Y. Mao Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE Nat Immunol 8 2007 487 496
35. N. Taniguchi, K. Kawahara, and K. Yone High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine Arthritis Rheum 48 2003 971 981
36. A.W. de Souza, J. Westra, P.C. Limburg, M. Bijl, and C.G. Kallenberg HMGB1 in vascular diseases: its role in vascular inflammation and atherosclerosis Autoimmun Rev 11 2012 909 917
37. K. Inoue, K. Kawahara, and K.K. Biswas HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques Cardiovasc Pathol 16 2007 136 143
38. X.X. Yan, L. Lu, and W.H. Peng Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients Atherosclerosis 205 2009 544 548
39. M. Andrassy, H.C. Volz, and N. Riedle HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction J Intern Med 270 2011 245 253
40. M. Andrassy, H.C. Volz, and A. Schuessler HMGB1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease PLoS One 7 2012 e52081
41. M. Andrassy, H.C. Volz, and J.C. Igwe High-mobility group box-1 in ischemia-reperfusion injury of the heart Circulation 117 2008 3216 3226
42. I. Marenholz, C.W. Heizmann, and G. Fritz S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature) Biochem Biophys Res Commun 322 2004 1111 1122
43. J. Pietzsch, and S. Hoppmann Human S100A12: a novel key player in inflammation? Amino Acids 36 2009 381 389
44. C. Perera, H.P. McNeil, and C.L. Geczy S100 calgranulins in inflammatory arthritis Immunol Cell Biol 88 2010 41 49
45. M.M. Averill, C. Kerkhoff, and K.E. Bornfeldt S100A8 and S100A9 in cardiovascular biology and disease Arterioscler Thromb Vasc Biol 32 2012 223 229
46. M.G. Ionita, A. Vink, and I.E. Dijke High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions Arterioscler Thromb Vasc Biol 29 2009 1220 1227
47. M.M. McCormick, F. Rahimi, and Y.V. Bobryshev S100A8 and S100A9 in human arterial wall. Implications for atherogenesis J Biol Chem 280 2005 41521 41529
48. S. Miyamoto, M. Ueda, and M. Ikemoto Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina Heart 94 2008 1002 1007
49. J. Goyette, and C.L. Geczy Inflammation-associated S100 proteins: new mechanisms that regulate function Amino Acids 41 2011 821 842
50. Z. Yang, W.X. Yan, and H. Cai S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity J Allergy Clin Immunol 119 2007 106 114
51. B.H. Ruan, X. Li, and A.R. Winkler Complement C3a, CpG oligos, and DNA/C3a complex stimulate IFN-alpha production in a receptor for advanced glycation end product-dependent manner J Immunol 185 2010 4213 4222
52. Y. Yamamoto, A. Harashima, and H. Saito Septic shock is associated with receptor for advanced glycation end products ligation of LPS J Immunol 186 2011 3248 3257
53. L. Ramsgaard, J.M. Englert, and M.L. Manni Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice PLoS One 6 2011 e20132
54. T. Sakaguchi, S.F. Yan, and S.D. Yan Central role of RAGE-dependent neointimal expansion in arterial restenosis J Clin Invest 111 2003 959 972
55. J.S. Huang, J.Y. Guh, H.C. Chen, W.C. Hung, Y.H. Lai, and L.Y. Chuang Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells J Cell Biochem 81 2001 102 113
56. H.J. Huttunen, J. Kuja-Panula, and H. Rauvala Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation J Biol Chem 277 2002 38635 38646
57. B.I. Hudson, A.Z. Kalea, and Arriero M. Del Mar Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42 J Biol Chem 283 2008 34457 34468
58. K. Ishihara, K. Tsutsumi, S. Kawane, M. Nakajima, and T. Kasaoka The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site FEBS Lett 550 2003 107 113
59. M. Sakaguchi, H. Murata, and K. Yamamoto TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding PLoS One 6 2011 e23132
60. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
61. R.R. Packard, and P. Libby Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction Clin Chem 54 2008 24 38
62. A. Soro-Paavonen, A.M. Watson, and J. Li Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes Diabetes 57 2008 2461 2469
63. A.P. Burke, F.D. Kolodgie, and A. Zieske Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study Arterioscler Thromb Vasc Biol 24 2004 1266 1271
64. C. Cuccurullo, A. Iezzi, and M.L. Fazia Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes Arterioscler Thromb Vasc Biol 26 2006 2716 2723
65. T.M. Wendt, N. Tanji, and J. Guo RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy Am J Pathol 162 2003 1123 1137
66. A. Bierhaus, K.M. Haslbeck, and P.M. Humpert Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily J Clin Invest 114 2004 1741 1751
67. C. Falcone, E. Emanuele, and A. D'Angelo Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men Arterioscler Thromb Vasc Biol 25 2005 1032 1037
68. H. Koyama, T. Shoji, and H. Yokoyama Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis Arterioscler Thromb Vasc Biol 25 2005 2587 2593
69. G.D. Norata, K. Garlaschelli, and L. Grigore Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population Nutr Metab Cardiovasc Dis 19 2009 129 134
70. N. Mahajan, A. Bahl, and V. Dhawan C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin Int J Cardiol 142 2010 273 278
71. Y. Zhong, S.H. Li, and S.M. Liu C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells Hypertension 48 2006 504 511
72. T. Hasegawa, A. Kosaki, and T. Kimura The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages Atherosclerosis 171 2003 211 218
73. B.I. Hudson, M.H. Stickland, and P.J. Grant Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups Diabetes 47 1998 1155 1157
74. M.A. Hofmann, S. Drury, and B.I. Hudson RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response Genes Immun 3 2002 123 135
75. E. Leclerc, G. Fritz, S.W. Vetter, and C.W. Heizmann Binding of S100 proteins to RAGE: an update Biochim Biophys Acta 1793 2009 993 1007
76. P.Y. Poon, C.C. Szeto, K.M. Chow, B.C. Kwan, and P.K. Li Relation between polymorphisms of receptor for advanced glycation end products (RAGE) and cardiovascular diseases in Chinese patients with diabetic nephropathy Clin Nephrol 73 2010 44 50
77. K. Pettersson-Fernholm, C. Forsblom, B.I. Hudson, M. Perola, P.J. Grant, and P.H. Groop The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients Diabetes 52 2003 891 894
78. Y. Jang, J.Y. Kim, and S.M. Kang Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans Metabolism 56 2007 199 205
79. B.I. Hudson, M.H. Stickland, T.S. Futers, and P.J. Grant Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy Diabetes 50 2001 1505 1511
80. J. Wang, L. Zou, and Z. Song Meta-analysis of RAGE gene polymorphism and coronary heart disease risk PLoS One 7 2012 e50790
81. D. Geroldi, C. Falcone, and E. Emanuele Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension J Hypertens 23 2005 1725 1729
82. K. Nakamura, H. Adachi, T. Matsui, Y. Kurita, M. Takeuchi, and S. Yamagishi Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients Metabolism 58 2009 421 425
83. S.J. Yoon, S. Park, and C. Park Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients Coron Artery Dis 23 2012 85 90
84. N. Mahajan, and V. Dhawan Potential biomarkers for disease activity in Takayasu's arteritis Int J Cardiol 158 2012 331
85. N. Mahajan, V. Dhawan, S. Mahmood, S. Malik, and S. Jain Extracellular matrix remodeling in Takayasu's arteritis: role of matrix metalloproteinases and adventitial inflammation Arch Med Res 43 2012 406 410
86. V. Dhawan, N. Mahajan, and S. Jain Role of C-C chemokines in Takayasu's arteritis disease Int J Cardiol 112 2006 105 111
87. N. Mahajan, S. Mahmood, S. Jain, and V. Dhawan Receptor for advanced glycation end products (RAGE), inflammatory ligand EN-RAGE and soluble RAGE (sRAGE) in subjects with Takayasu's arteritis Int J Cardiol 2013 10.1016/j.ijcard.2013.01.002
88. N. Mahajan, V. Dhawan, S. Malik, and S. Jain Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's arteritis disease Int J Cardiol 145 2010 286 288
89. T. Kawasaki, F. Kosaki, S. Okawa, I. Shigematsu, and H. Yanagawa A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan Pediatrics 54 1974 271 276
90. A. Suzuki, T. Kamiya, Y. Arakaki, Y. Kinoshita, and K. Kimura Fate of coronary arterial aneurysms in Kawasaki disease Am J Cardiol 74 1994 822 824
91. D. Foell, F. Ichida, and T. Vogl S100A12 (EN-RAGE) in monitoring Kawasaki disease Lancet 361 2003 1270 1272
92. H. Wittkowski, K. Hirono, and F. Ichida Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12 Arthritis Rheum 56 2007 4174 4181
93. F. Gong, Y. Zhang, and C. Xie Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease Pediatr Res 71 2012 720 724
94. Y. Qi, F. Gong, Q. Zhang, C. Xie, W. Wang, and S. Fu Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease Arthritis Res Ther 14 2012 R251
95. K. de Leeuw, R. Graaff, and R. de Vries Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus Rheumatology (Oxford) 46 2007 1551 1556
96. K. de Leeuw, B. Freire, A.J. Smit, H. Bootsma, C.G. Kallenberg, and M. Bijl Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus Lupus 15 2006 675 682
97. D.A. Abdulahad, J. Westra, J. Bijzet, P.C. Limburg, C.G. Kallenberg, and M. Bijl High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus Arthritis Res Ther 13 2011 R71
98. H.A. Martens, H.L. Nienhuis, and S. Gross Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis Lupus 21 2012 959 968
99. H.L. Nienhuis, K. de Leeuw, and J. Bijzet Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts Rheumatology (Oxford) 47 2008 1554 1558